Europass curriculum vitae

Curriculum Vitae
Personal information
First name(s) / Surname(s) Andrea Lenzi
Address(es) Department of Experimental Medicine University of Rome “Sapienza” Viale Regina Elena 324 Occupational field Endocrinology, Andrology and Reproduction Medicine
Work experience
Full Professor of Endocrinology
Degree course in Medicine at the University of Rome “Sapienza” President


Masters in Andrology University of Rome “Sapienza” Director

Master E-learning in the health area
University of Rome "Sapienza"
National Conference of Degree Courses in Medicine and Surgery
National Conference of the permanent contact of the Area Health Education specialization
Department of Medical Pathophysiology
University of Rome "Sapienza"
For more information on Europass go to ht p:/ Surname(s) First name(s) European Union, 2004-2010 24082010 2007
National University Council (CUN)

National University Council (CUN) Medical Sciences Area Committee

MIUR – Committee of “Rientro dei Cervelli”

National Commission for Healthcare Research

Ministry of Defence - Technical and Scientific Committee, "Evaluation of the male reproductive tract diseases in
military personnel engaged in operational theaters"
Vice President

PhD in Andrology Endocrinology and Metabolism
University of Rome "Sapienza"
Board of the University of Rome IV “Foro Italico”.
"Working Group, Joint Technical Table for biomedical research”
Ministry of Labour, Health and Social Policy – MIUR
National Commission for Continuing Medical Education
Scientific Committee of the board of Eli-Lilly and the International Review of Research Projects of the Foundation. Coordinator
"Research Consortium for the Development of Innovative Platforms in the field of biomedical technology - PiTecnoBio" President Interuniversity Research Centre for Experimental Andrology (CASPER).

Agenzia Italiana del Farmaco (AIFA) Group - Andrological Issues
Non-profit foundation for wellness in Andrology “AmicoAndrologo”. President College of Full Professor in Endocrinology President Dept Experimental Medicine - University of Rome "Sapienza" Section of Medical Pathophysiology, Food Science and Endocrinology Chairman
National Committee for Biosafety, Biotechnology and Life Sciences of the Prime Minister and coordinator of the
Observatory for Biotechnology Vice President Collaboration between the "Sapienza" University of Rome and the Ministry of Health on the Project Fertility - Academy of Fertility For more information on Europass go to ht p:/ Surname(s) First name(s) European Union, 2004-2010 24082010 Education and training
Graduated in Medicine
University of Rome Sapienza
Post-graduated in Andrology
University of Pisa
Post-graduated in Physiopathology of Reproduction
Specialized in Immunology and Epidemiology (Paris-Inst. Pasteur)
Specialized in Assisted Reproduction Technology
Personal skills and
Mother tongue(s) Italian
Additional information SCIENTIFIC ACTIVITY
Scientific activity is in the field of Clinical and Laboratory aspects of Endocrinology and Andrology. - Coordinator of Research Units financed by the National Research Council, Ministry of Universities, National Institute of Health, and the University of Rome Sapienza. - Secretary General of International Society for Immunology of Reproduction (ISIR) 1999-2004; - Secretary General of Alps-Adria Society for Immunology of Reproduction (AASIR) 1998-2001; - Secretary General of Executive Council of European Academy of Andrology (EAA) 2002-2010; - Permanent Member of Special Interests Study Group for Andrology of the European Society of Human Reproduction and Embryology (ESHRE); - Vice President of Italian Society of Physiopathology of Reproduction (SIFR) 2002-2005; - Secretary of Executive Council of Italian Society of Endocrinology (SIE) 2003-2007;
- President of Italian Society of Andrology and Medical Sexology (SIAMS) 2008-2010;
- Member of several Academic Societies including: American Society of Andrology; American Society of Immunology of
Reproduction; American Society of Fertility and Sterility; The American Endocrine Society;
- Member of the Editorial Board of several international scientific journals;
- Publication of more than 600 papers, review and chapters in national and international Journals, Books and Proceedings (more
than 220 original papers in the main International Journals in the area of research IF 629,51 - H Index 32).


- Director of Unit of Andrology, Reproductive Physiopathology and Endocrine Diagnosis - Coordinator of Laboratories of Endocrinology in the Policlinico Umberto I University Hospital For more information on Europass go to ht p:/ Surname(s) First name(s) European Union, 2004-2010 24082010 Selection of Scientific Publication Ten out of more than 600 papers from 1979 to 2012
Dondero F, Isidori A, Lenzi A, Cerasaro M, Mazzilli F, Giovenco P, Conti C. Treatment and follow-up of patients with infertility due to spermagglutinins. Fertil Steril. 1979
Isidori A, Dondero F, Lenzi A. Immunobiology of male infertility. Hum Reprod. 1988 Jan;3(1):75-7
Lenzi A, Picardo M, Gandini L, Dondero F. Lipids of the sperm plasma membrane: from polyunsaturated fat y acids considered as markers of sperm function to possible
scavenger therapy. Hum Reprod Update. 1996 May-Jun;2(3):246-56. Lenzi A, Lombardo F, Sgrò P, Salacone P, Caponecchia L, Dondero F, Gandini L. Use of carnitine therapy in selected cases of male factor infertility: a double-blind
crossover trial. Fertil Steril. 2003 Feb;79(2):292-300. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid
patients. J Clin Endocrinol Metab. 2005 Dec;90(12):6472-9. Morano S, Mandosi E, Fallarino M, Gat i A, Tiberti C, Sensi M, Gandini L, Buchet i B, Lenti L, Jannini EA, Lenzi A. Antioxidant treatment associated with sildenafil reduces
monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. Eur Urol. 2007 Dec;52(6):1768-74. Di Luigi L, Baldari C, Sgrò P, Emerenziani GP, Gallot a MC, Bianchini S, Romanelli F, Pigozzi F, Lenzi A, Guidet i L. The type 5 phosphodiesterase inhibitor tadalafil
influences salivary cortisol, testosterone, and dehydroepiandrosterone sulphate responses to maximal exercise in healthy men. JClin Endocrinol Metab. 2008
Capizzi M, Leto G, Petrone A, Zampet i S, Papa RE, Osimani M, Spoletini M, Lenzi A, Osborn J, Mastantuono M, Vania A, Buzzet i R. Wrist circumference is a clinical
marker of insulin resistance in overweight and obese children and adolescents. Circulation. 2011 Apr 26;123(16):1757-62.
Aversa A, Letizia C, Francomano D, Bruzziches R, Natali M, Lenzi A. A spontaneous, double-blind, double-dummy cross-over study on the ef ects of daily vardenafil on
arterial stiffness in patients with vasculogenic erectile dysfunction. Int J Cardiol. 2011 May 5
10. Giannet a E, Isidori AM, Galea N, Carbone I, Mandosi E, Vizza CD, Naro F, Morano S, Fedele F, Lenzi A Chronic Inhibition of cGMP Phosphodiesterase 5A Improves
Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging. CIRCULATION, vol. 125, p. 2323-2333, Guida allo studio dell'endocrinologia. D'Armiento M, Dondero F, Lenzi A. SEU 2010. Endocrinologia clinica. Lenzi A, Lombardi G, Martino E. Minerva Medica 2010. Diagnostica per immagini dello spermatozoo umano. Gandini L., Lombardo F., Paoli D., Lenzi A. Carocci Editore, 2010. Scrotal Ultrasound: Morphological and Functional atlas. Isidori AM, Lenzi A. Forum Service 2008. Sessuologia Medica Trat ato di psicosessuologia e medicina della sessualità. Jannini EA, Lenzi A, Maggi M. Elsevier Masson 2007. For more information on Europass go to ht p:/ Surname(s) First name(s) European Union, 2004-2010 24082010


Microsoft word - iv push policy updated final may 201

The University of Kansas Hospital Corporate Policy Manual Volume : Patient Care Section: Medication Management POLICY Title: Administration of IV Push Medications on non-critical care units Signature __________________________________________________________________ Tammy Peterman / Executive Vice-President, Chief Operating Officer, Formulation:___4/2009______ Revised

Solutions DiSability inSurance By Carolyn Jackson, MD Senior Medical Director Howard, 49, a business owner, has applied for disability insurance with a 90-day elimination period (EP). Four years Depression is one of the most common mental health ago, he went through a very emotionally traumatic separation disorders in the United States. According to the National and divorce after 12

Copyright © 2010 Health Drug Pdf